Professional Marketing briefs

Cegedim Dendrite will deploy a new customer help-desk tool to clients worldwide. Amdocs' Smart Agent Desktop, will automate current processes so that pharma clients receive global reports that help them pinpoint worldwide support issues.

Eisai received a DDMAC warning letter for a Dacogen patient-profile card, a sales aid used when detailing physicians. DDMAC said the card was misleading, because it minimizes risks, overstates efficacy and omits material facts.

Celgene is poised to bring Istodax to market after acquiring the firm that oversaw development, Gloucester Pharmaceuticals. An early 2010 launch is planned for the lymphoma drug.

A recommendation issued by the New Jersey Division of Consumer Affairs calls for a new Board of Medical Examiners rule requiring that 25% of licensed physicians' CME be obtained in evidence-based educational programs or academic detailing.
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.